인쇄하기
취소
|
Insurance benefits of ‘Pradaxa’ and ‘Eliquis’ will be available on treating and preventing reoccurrence of deep vein thrombosis (DVT) and pulmonary Embolism (PE).
The Ministry of Health and Welfare made an official announcement related to details of application standards and methods for the insurance benefit. Thus, the insurance benefit will be registered the specific indications from the comi...